Skip to main content
. 2021 Jan 13;19:4. doi: 10.1186/s12915-020-00936-8

Table 1.

Lipid composition of membranes under study

Name Lipid composition a Tail composition b
SimplePOM 5% MPPO-CL 39% (P) 16:0
23% MMPG 37% (O) 18:1 cis9,10
72% POPE 24% (M) cy17:0 cis9,10
SimplePVJ 5% JPPV-CL 39% (P) 16:0
23% JJPG 37% (V) 18:1 cis11,12
72% PVPE 24% (J) cy17:0 cis11,12
SimplePVM 5% MPPV-CL 39% (P) 16:0
23% MMPG 37% (V) 18:1 cis11,12
72% PVPE 24% (M) cy17:0 cis19,10
Avanti 1.0% YPMN-CL
1.0% YPMV-CL
2.1% MPPV-CL
0.5% MPPM-CL
12.4% PMPG
2.1% PNPG 37.4% (P) 16:0
1.0% YVPG 28.0% (V) 18:1 cis11,12
4.1% PVPG 21.0% (M) cy17:0 cis9,10
2.1% PYPG 9.4% (Y) 16:1 cis9,10
14.5% YVPE 4.2% (N) cy19:0 cis11,12
17.6% PMPE
5.7% PNPE
8.8% MVPE
26.9% PVPE

aMolecular fraction of individual lipids; b Percentage of lipid tails, shortcuts are given in brackets. CL cardiolipin, PG phosphatidylglycerol, PE phosphatidylethanolamine, P palmitoyl, Mcis-9,10-methylene-hexadecanoic-acid, Ncis-11,12-methylene-octadecanoic-acid, Ycis-11,12-octadecenoic-acid, V palmitoleic acid, O oleic acid, Jcis-11,12-methylene-hexadecanoic-acid. For chemical structure, see Additional file 1: Figs. S1-S3. The proportion of saturated, unsaturated, and cyclopropane-containing tails of both models represents equally well recent experiments [51, 67, 112]